Company · CIK 0001612940 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ProQR Therapeutics N.V. · PRQR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 PForm 4 → | Aug 3, 4:01 pm EDT | Daniel Anton de BoerChief Executive Officer, Director | 200,000 | $1.77 | $353,960 | 500,000 | +66.7% | |
| Jul 17, 2026 PForm 4 → | Jul 21, 8:00 am EDT | Bart FiliusDirector | 150,000 | $1.72 | $257,925 | 300,000 | +100% | |
| Jul 9, 2026 PForm 4 → | Jul 13, 8:00 am EDT | Daniel Anton de BoerChief Executive Officer, Director | 150,000 | $1.74 | $261,000 | 300,000 | +100% | |
| Jul 7, 2026 PForm 4 → | Jul 8, 2:55 pm EDT | Daniel Anton de BoerChief Executive Officer, Director | 150,000 | $1.59 | $238,500 | 150,000 | — | |
| Jun 26, 2026 PForm 4 → | Jun 30, 4:01 pm EDT | Bart FiliusDirector | 150,000 | $1.54 | $231,000 | 150,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 AForm 4/A → | Jun 30, 4:02 pm EDT | Gylvin Lykke HinschDirector | 14,595 | — | — | 14,595 | — | |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:01 pm EDT | Gylvin Lykke HinschDirector | 14,495 | — | — | 14,495 | — | amended |